Unicycive Therapeutics Inc UNCY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.04quote price arrow up+0.01 (+0.97%)
Volume
220,298
52 week range
0.47 - 1.82
Loading...
  • Open1.05
  • Day High1.06
  • Day Low1.01
  • Prev Close1.03
  • 52 Week High1.82
  • 52 Week High Date06/12/23
  • 52 Week Low0.47
  • 52 Week Low Date11/14/23

Key Stats

  • Market Cap39.111M
  • Shares Out37.61M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.71
  • YTD % Change18.7

KEY STATS

  • Open1.05
  • Day High1.06
  • Day Low1.01
  • Prev Close1.03
  • 52 Week High1.82
  • 52 Week High Date06/12/23
  • 52 Week Low0.47
  • 52 Week Low Date11/14/23
  • Market Cap39.111M
  • Shares Out37.61M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.71
  • YTD % Change18.7

RATIOS/PROFITABILITY

  • EPS (TTM)-1.26
  • P/E (TTM)-0.83
  • Fwd P/E (NTM)-1.57
  • EBITDA (TTM)-25.761M
  • ROE (TTM)-722.08%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-4,525.04%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Unicycive Therapeutics Inc

 

Profile

MORE
Unicycive Therapeutics, Inc. is a biotechnology company that is developing treatments for certain medical conditions. Its programs are focused on kidney disease, an area that has the potential to offer medical benefits. Its development programs are focused on two novel therapies: Oxylanthanum Carbonate, and UNI 494. Oxylanthanum Carbonate is a novel investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease...
Shalabh Gupta M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
John Townsend
Chief Financial Officer
Pramod Gupta Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Doug Jermasek
Executive Vice President, Corporate Strategy
Address
4300 El Camino Real, Suite 210
Los Altos, CA
94022
United States

Top Peers

SYMBOLLASTCHG%CHG
TCRT
Alaunos Therapeutics Inc
1.16-0.06-4.92%
IMRX
Immuneering Corp
1.47-0.07-4.55%
XLO
Xilio Therapeutics Inc
1.14+0.06+5.56%
MTNB
Matinas BioPharma Holdings Inc
0.17-0.003-1.7341%
INAB
IN8BIO, Inc.
1.03+0.01+0.98%